CDX2 IHC Test for Tumor Origin | Lahalak Platform
A specialized tissue analysis detecting CDX2 protein to accurately determine tumor origin, particularly colorectal cancer, ensuring the selection of the most effective treatment plan.
Scientific name: Immunohistochemistry: CDX2
Immunohistochemical (IHC) assays detect the nuclear expression of the transcription factor CDX2 (Caudal Type Homeobox 2). CDX2 is normally expressed in the nuclei of epithelial cells lining the midgut and embryonic cloaca, and persists in the mature epithelial cells of the small intestine, colon, and rectum. In diagnostic pathology, CDX2 is a highl...
Service type
Immunohistochemistry (IHC) Test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Detailed analysis to detect nuclear expression of the CDX2 protein in tumor tissue samples.
- Consult with a pathologist and a gastrointestinal oncologist to interpret the results.
- Personal support services from Halak.
Medical Service Information
Conditions & Notices
- The analysis does not require the patient to fast, as it is performed on a fixed tissue sample.
- The need for a sufficient tumor tissue sample (biopsy or excision).
- It is often requested as part of a diagnostic package for metastatic tumors of unknown origin or for classifying gastrointestinal/ovarian tumors. This package typically includes CDX2, CK7, CK20, SATB2, and markers specific to the suspected site.
Medical services you might also like
